Propanc Biopharma, Inc. Common Stock (PPCB)

US · Healthcare · Biotechnology

$0.34+0.15%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Net profit

$-4.6M

EPS

$-0.39

EPS estimate

$0.00

Market cap

$4.8M

Forward P/E

0.0

P/B

0.14

Book value

$11.24

EPS (TTM)

$-17.62

52-week high

$47.50

52-week low

$0.42

50-day MA

$0.93

200-day MA

$3.32

Beta

3.33

with an average price target of $1.52.

Insiders

62.20%

Institutions

0.76%

Fund	Stake
Jane Street Group LLC	0.40%
Citadel Advisors Llc	0.19%
HRT FINANCIAL LLC	0.16%
Caitong International Asset Management Co., Limited.	0.00%
Mercer Global Advisors Inc.	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Sassicaia Capital Advisers LLC	0.00%
Two Sigma Investments LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Propanc Biopharma, Inc. Common Stock — free to start.

Data updated 2026-10-18.